Craneware PLC
LSE:CRW

Watchlist Manager
Craneware PLC Logo
Craneware PLC
LSE:CRW
Watchlist
Price: 1 564 GBX 2.49% Market Closed
Market Cap: £546.8m

EV/EBITDA

11
Current
26%
Cheaper
vs 3-y average of 14.8

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
11
=
Enterprise Value
GBX479.2m
/
EBITDA
$64.6m

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
11
=
Enterprise Value
GBX479.2m
/
EBITDA
$64.6m

Valuation Scenarios

Craneware PLC is trading below its 3-year average

If EV/EBITDA returns to its 3-Year Average (14.8), the stock would be worth GBX2 119.45 (36% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-100%
Maximum Upside
+49%
Average Downside
29%
Scenario EV/EBITDA Value Implied Price Upside/Downside
Current Multiple 11 GBX1 564
0%
3-Year Average 14.8 GBX2 119.45
+36%
5-Year Average 16.3 GBX2 326.08
+49%
Industry Average 0 GBX3.46
-100%
Country Average 0 GBX2.81
-100%

Forward EV/EBITDA
Today’s price vs future ebitda

Today's Enterprise Value EBITDA Forward EV/EBITDA
GBX479.2m
/
Jan 2026
$64.6m
=
11
Current
GBX479.2m
/
Jun 2026
$72.8m
=
6.6
Forward
GBX479.2m
/
Jun 2027
$80.1m
=
6
Forward
GBX479.2m
/
Jun 2028
$86.8m
=
5.5
Forward

Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.

Peer Comparison

All Multiples
EV/EBITDA
P/E
All Countries
Close
Market Cap EV/EBITDA P/E
UK
Craneware PLC
LSE:CRW
553.8m GBP 11 31.6
US
Cerner Corp
LSE:0R00
31.3B USD 21.9 53.1
US
Veeva Systems Inc
NYSE:VEEV
25.6B USD 19.1 28.1
AU
Pro Medicus Ltd
ASX:PME
14.8B AUD 76.7 61.9
JP
M3 Inc
TSE:2413
1T JPY 9.8 20.2
SE
Sectra AB
STO:SECT B
52.1B SEK -134.4 97
US
Waystar Holding Corp
NASDAQ:WAY
4.8B USD 15 41.5
US
Doximity Inc
NYSE:DOCS
4.3B USD 14.1 17.9
US
Heartflow Inc
NASDAQ:HTFL
2.7B USD 0 0
CN
Winning Health Technology Group Co Ltd
SZSE:300253
19.3B CNY -122.4 -62.7
US
Vocera Communications Inc
F:V00
2.4B EUR 267.9 -328
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Craneware PLC
LSE:CRW
Average EV/EBITDA: 54.4
11
12%
0.9
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
19.1
28%
0.7
AU
Pro Medicus Ltd
ASX:PME
76.7
28%
2.7
JP
M3 Inc
TSE:2413
9.8
14%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -134.4 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
15
20%
0.7
US
Doximity Inc
NYSE:DOCS
14.1
21%
0.7
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -122.4
36%
N/A
US
V
Vocera Communications Inc
F:V00
267.9
N/A N/A
P/E Multiple
Earnings Growth PEG
UK
Craneware PLC
LSE:CRW
Average P/E: 43.9
31.6
39%
0.8
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
28.1
25%
1.1
AU
Pro Medicus Ltd
ASX:PME
61.9
29%
2.1
JP
M3 Inc
TSE:2413
20.2
16%
1.3
SE
Sectra AB
STO:SECT B
97
14%
6.9
US
W
Waystar Holding Corp
NASDAQ:WAY
41.5
55%
0.8
US
Doximity Inc
NYSE:DOCS
17.9
15%
1.2
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -62.7
69%
N/A
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328 N/A N/A

Market Distribution

Higher than 95% of companies in United Kingdom
Percentile
95th
Based on 1 967 companies
95th percentile
11
Low
0 — 0
Typical Range
0 — 0
High
0 —
Distribution Statistics
United Kingdom
Min 0
30th Percentile 0
Median 0
70th Percentile 0
Max 743.2

Craneware PLC
Glance View

Market Cap
546.8m GBX
Industry
Health Care

Craneware PLC, a prominent player in the healthcare software industry, crafts its narrative in the pursuit of financial optimization for hospitals across the United States. Established in 1999, Craneware recognized that hospitals were grappling with intricate billing processes and revenue cycle inefficiencies. By focusing on developing comprehensive software solutions, Craneware has strategically positioned itself to help these institutions navigate the labyrinth of medical billing and coding. With its suite of services, including charge capture, pricing analytics, and cost management, Craneware aids hospitals in maximizing their revenue and ensuring compliance. This focus allows healthcare providers to transform data into actionable insights, which not only streamlines operations but also enhances fiscal performance. Revenue generation for Craneware comes primarily from its software sales and accompanying support services. The company employs a Software as a Service (SaaS) model, wherein clients subscribe to its offerings on a recurring basis, ensuring a steady inflow of income while fostering long-term business relationships. This model capitalizes on the growing demand for cloud-based solutions, providing clients with the flexibility and scalability required in a constantly evolving healthcare landscape. Craneware’s unique positioning at the intersection of healthcare and financial management means its growth is not just dependent on acquiring new clients, but also on deepening engagements with existing ones, providing upgrades and enhancements that serve the ever-changing needs of the healthcare industry.

CRW Intrinsic Value
1 296.78 GBX
Overvaluation 17%
Intrinsic Value
Price GBX1 564
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett